Search research articles
Contact Us
Filters
Showing results (291-300 of 527) with videos related to
Page
of 53
Sort By:
Targeted Oncology
|
October 14, 2025
A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer
Richard S Finn, Hope S Rugo, Javier Cortes, et al.
Frontiers in Oncology
|
February 20, 2026
Advancements in intratumoral therapies for liver tumors
Steven S Raman, Neal R Cutler, John J Sramek, et al.
Psychological Science
|
April 22, 2015
Neuroanatomical correlates of the income-achievement gap
Allyson P Mackey, Amy S Finn, Julia A Leonard, et al.
BMC Cancer
|
January 17, 2012
Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study
Carolyn D Britten, Antoinette S Gomes, Zev A Wainberg, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 18, 2023
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M Llovet, Catherine E Willoughby, Amit G Singal, et al.
Journal of Affective Disorders
|
October 20, 2023
Polygenic risk for depression and anterior and posterior hippocampal volume in children and adolescents
Hailee Hurtado, Melissa Hansen, Jordan Strack, et al.
The American Journal of Pathology
|
November 7, 2001
Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p
S C Abraham, T T Wu, D S Klimstra, et al.
Hepatology (Baltimore, Md.)
|
January 10, 2013
Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro
Richard S Finn, Alexey Aleshin, Judy Dering, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Evidence for aggregation-independent, PrP<sup>C</sup>-mediated Aβ cellular internalization
Alejandro R Foley, Graham P Roseman, Ka Chan, et al.
Breast Cancer Research and Treatment
|
March 7, 2026
Comparative effectiveness of CDK4/6 inhibitors in metastatic breast cancer: using the target trial emulation framework to investigate overall survival in routine care
Adam M Brufsky, Richard S Finn, Otto Metzger, et al.
Page
of 53
Search research articles
Search
Showing results (291-300 of 527) with videos related to
Sort By:
Page
of 53
Targeted Oncology
|
October 14, 2025
A Decade After Approval of the First CDK4/6 Inhibitor: A Look Back at Palbociclib's Journey from Discovery to Approval and What's Next in CDK Inhibition in Breast Cancer
Richard S Finn, Hope S Rugo, Javier Cortes, et al.
Frontiers in Oncology
|
February 20, 2026
Advancements in intratumoral therapies for liver tumors
Steven S Raman, Neal R Cutler, John J Sramek, et al.
Psychological Science
|
April 22, 2015
Neuroanatomical correlates of the income-achievement gap
Allyson P Mackey, Amy S Finn, Julia A Leonard, et al.
BMC Cancer
|
January 17, 2012
Transarterial chemoembolization plus or minus intravenous bevacizumab in the treatment of hepatocellular cancer: a pilot study
Carolyn D Britten, Antoinette S Gomes, Zev A Wainberg, et al.
Nature Reviews. Gastroenterology & Hepatology
|
March 18, 2023
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment
Josep M Llovet, Catherine E Willoughby, Amit G Singal, et al.
Journal of Affective Disorders
|
October 20, 2023
Polygenic risk for depression and anterior and posterior hippocampal volume in children and adolescents
Hailee Hurtado, Melissa Hansen, Jordan Strack, et al.
The American Journal of Pathology
|
November 7, 2001
Distinctive molecular genetic alterations in sporadic and familial adenomatous polyposis-associated pancreatoblastomas : frequent alterations in the APC/beta-catenin pathway and chromosome 11p
S C Abraham, T T Wu, D S Klimstra, et al.
Hepatology (Baltimore, Md.)
|
January 10, 2013
Molecular subtype and response to dasatinib, an Src/Abl small molecule kinase inhibitor, in hepatocellular carcinoma cell lines in vitro
Richard S Finn, Alexey Aleshin, Judy Dering, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
November 3, 2020
Evidence for aggregation-independent, PrP<sup>C</sup>-mediated Aβ cellular internalization
Alejandro R Foley, Graham P Roseman, Ka Chan, et al.
Breast Cancer Research and Treatment
|
March 7, 2026
Comparative effectiveness of CDK4/6 inhibitors in metastatic breast cancer: using the target trial emulation framework to investigate overall survival in routine care
Adam M Brufsky, Richard S Finn, Otto Metzger, et al.
Page
of 53